Evidence map›Paper›PMID 41409356›Full record

ArticleFrontiers in medicine2025

Successful treatment of pulmonary lymphatic perfusion syndrome with lymphatic intervention embolization: a case report.

Qunxiang Liu, JiaQi Wang, Yingjie Chen, Wei Qin, Ziyang Zhu

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qunxiang Liu *Department of Pulmonary and Critical Care Medicine, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.
JiaQi Wang *Department of Pulmonary and Critical Care Medicine, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.
Yingjie ChenDepartment of Pulmonary and Critical Care Medicine, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.
Wei QinDepartment of Pulmonary and Critical Care Medicine, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.
Ziyang ZhuDepartment of Pulmonary and Critical Care Medicine, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary Lymphatic Perfusion Syndrome (PLPS) is a rare condition characterized by abnormal lymphatic drainage into the lungs, leading to symptoms such as chyloptysis and chylous effusions. We report a case of a 54-year-old male with PLPS who presented with persistent cough, milky sputum, and pericardial effusion. Following initial misdiagnosis and ineffective empirical treatment for a presumed pulmonary infection, a definitive diagnosis of PLPS was established. The patient underwent successful percutaneous thoracic duct embolization, resulting in complete resolution of symptoms and imaging findings at follow-up. This case highlights the importance of considering PLPS in patients with unexplained chylous effusions and the efficacy of lymphatic intervention as a treatment option.

Indexed as

chyloptysis/milky sputumchylous pericardial effusionlymphatic interventionpulmonary lymphatic perfusion syndrome (PLPS)thoracic duct embolization

Identifiers

PMID41409356
PMCPMC12705354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.